---
title: "US Stock Market News | Adjusted net profit for the second quarter of 2024 increased by 7% year-on-year, YUM China rose more than 2%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/216469979.md"
description: "On Thursday, YUM CHINA's stock price opened more than 3% higher, and as of the time of publication, it had risen over 2% to $47.66. In terms of news, YUM CHINA achieved revenue of $5.64 billion in 1H24, up 1% year-on-year; adjusted net profit was $499 million, up 2% year-on-year. In 2Q24, revenue reached $2.68 billion, up 1% year-on-year, adjusted net profit was $212 million, up 7% year-on-year; diluted EPS was $0.55, an increase of 17% year-on-year"
datetime: "2024-10-10T14:31:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/216469979.md)
  - [en](https://longbridge.com/en/news/216469979.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/216469979.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/216469979.md) | [English](https://longbridge.com/en/news/216469979.md)


# US Stock Market News | Adjusted net profit for the second quarter of 2024 increased by 7% year-on-year, YUM China rose more than 2%

According to the information from Zhitong Finance APP, on Thursday, YUM China (YUMC.US) opened more than 3% higher, and as of the time of publication, it rose more than 2% to $47.66. In terms of news, YUM China achieved revenue of $5.64 billion in 1H24, up 1% year-on-year; adjusted net profit was $499 million, up 2% year-on-year. In 2Q24, revenue reached $2.68 billion, up 1% year-on-year, adjusted net profit was $212 million, up 7% year-on-year; diluted EPS was $0.55, an increase of 17% year-on-year

### 相關股票

- [YUM China (YUMC.US)](https://longbridge.com/zh-HK/quote/YUMC.US.md)
- [YUM CHINA (09987.HK)](https://longbridge.com/zh-HK/quote/09987.HK.md)

## 相關資訊與研究

- [Zhongtai Securities Sticks to Its Buy Rating for Wasion Holdings Limited (3393)](https://longbridge.com/zh-HK/news/281141455.md)
- [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/zh-HK/news/281323250.md)
- [Rio Silver Books First Niñobamba Royalty, Secures More Magma Shares](https://longbridge.com/zh-HK/news/281389275.md)
- [Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform](https://longbridge.com/zh-HK/news/281413171.md)
- [Guotai Haitong Remains a Buy on Jinxin Fertility Group Ltd. (1951)](https://longbridge.com/zh-HK/news/281098586.md)